Posted by Next Big Futures on Tuesday, October 10, 2018 06:33:24In this video, gbsMedical is offering a treatment that will dramatically improve the recovery of patients with traumatic brain injury (TBI) including those who suffer from PTSD.
The treatment is called the ECT treatment, which is the same as a sedative and sedative-hypnotic agent that can be administered by injection to an individual’s central nervous system.
The ECT process involves the injection of a liquid substance into the brain, which causes the individual to experience a reduction in the amount of the neurotransmitter glutamate, the brain’s chemical messenger, which can be very important for a person’s memory, concentration, and alertness.TBI sufferers often experience a feeling of hopelessness, which may be triggered by a traumatic event that occurred long ago.
These sufferers also may experience extreme anxiety and depression, which are often worsened by prolonged use of medications.
The ECT technique uses a different medication than other sedatives and hypnotics, which means that the person’s brain doesn’t have to adapt to the changes that it is exposed to.ECT has the ability to drastically improve the brain function, which often improves after a traumatic incident, but for many people, the medication may not be effective enough to reverse the symptoms.
However, this is where the Ect Treatment comes in.
The new treatment will allow the patient to feel better and improve their cognition.
It’s important to note that this is an entirely new treatment and has not been used in the past by any medical or mental health company.
The company claims that this treatment is not only effective, but will help people recover faster and have a better quality of life.
While this treatment may be extremely promising for patients with TBI, some experts warn that it may not always work.
The drug can cause side effects and the medication must be taken regularly for the best results.
This may cause the person to suffer from severe side effects.
Another concern is that the medication has the potential to cause permanent damage to the brain and that it could potentially lead to permanent brain damage.
It’s also important to understand that while this treatment could potentially make a person better, it will not always be effective.
If the treatment is discontinued due to the side effects, it can be difficult to find a new treatment that offers the same or better results.
For patients with PTSD, there are many treatments available, but this new treatment is unique in that it targets the brain as a whole.
This new treatment uses a technique called optogenetics to make the patient’s brain work differently from normal brain function.
This new treatment was developed in collaboration with scientists from the Max Planck Institute of Psychiatry in Germany.
Dr. Joachim Hildreth, the co-director of the Max-Planck Institute, and Dr. Rolf Lohmann from the Institute for Brain Science in Berlin, are working to develop a method for creating new proteins and molecules that will change the brain in a way that is similar to the way a brain becomes more active.
This approach, called optogenic protein delivery, allows a brain cell to be activated when certain molecules are injected into it.
This is a new way of thinking that allows researchers to create new proteins that can stimulate brain cells in the brain.
Dr. Hildret explained,The optogenic treatment has the same chemical makeup as an anti-inflammatory drug.
It has the exact same structure as a drug that we would use to treat inflammation, which helps regulate the body’s immune system.
And it has the power to improve brain function and memory.
Dr Hildre said, The optogenetic therapy we are using now, called the Optogenetics, is an interesting approach because it is designed to target the central nervous systems of a brain.
This makes the brain very active, and in the future, we may use it to treat neurodegenerative diseases like Parkinson’s disease and traumatic brain injuries.
This is the first time in history that we have developed a treatment for traumatic brain disease, which affects about one in five people in the United States.
However even though this treatment works for people with PTSD and traumatic symptoms, there is a long way to go before it is available in the US.
The goal is to eventually develop a treatment to treat all of the symptoms of traumatic brain disorders.
According to Dr. Hilde, this treatment should be able to reduce the severity of symptoms in most people, but there are still questions about how effective this treatment will be in patients with no symptoms.
Dr Hildrey said, I am optimistic about the prospects of this treatment in the long run.
This treatment could be a game changer for a lot of people in recovery.